MedPath

To study the effect of Rasotanjan and Kasisanjan in the management of Arjuna

Phase 2
Conditions
Health Condition 1: H113- Conjunctival hemorrhage
Registration Number
CTRI/2022/01/039076
Lead Sponsor
Hon Shri Annasaheb Dange Ayurved Medical College and Post Graduate Research Centre Ashta
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients having Lakshanas of Arjuna Vyadhi

-Patients with age group of 18-60 years

-Patients having ocular trauma with sub-conjunctival haemorrhage without visual loss

-Patients complaining of spontaneous ocular haemorrhage along with history of hypertension, cough, vomiting etc. without visual loss

Exclusion Criteria

-Patient having age below 18 years and above 60 years

-Recently operated eye

-Patients with other ocular disease like corneal ulcer, mucopurulent

conjunctivitis etc.

-Traumatic patients with sub- conjunctival haemorrhage with visual loss

with retinal involvement are excluded

-Blood disorder having leukemia , purpura excluded

-Post Covid-19 patients with present complications

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rasotanjan is effective in ArjunaTimepoint: 15 days
Secondary Outcome Measures
NameTimeMethod
Kasisanjan is effective in ArjunaTimepoint: 15 days
© Copyright 2025. All Rights Reserved by MedPath